Cargando…
Hepatitis B Virus Virions Produced Under Nucleos(t)ide Analogue Treatment Are Mainly Not Infectious Because of Irreversible DNA Chain Termination
Nucleos(t)ide analogues (NAs) have been widely used for the treatment of chronic hepatitis B (CHB). Because viral DNA polymerase lacks proofreading function (3′ exonuclease activity), theoretically, the incorporated NAs would irreversibly terminate viral DNA synthesis. This study explored the nature...
Autores principales: | Liu, Yongzhen, Liu, Hui, Hu, Zhanying, Ding, Yang, Pan, Xiao‐Ben, Zou, Jun, Xi, Jingyuan, Yu, Guangxin, Huang, Hongxin, Luo, Meng‐Ting, Guo, Fang, Liu, Shuang, Sheng, Qiuju, Jia, Jidong, Zheng, Yong‐Tang, Wang, Jie, Chen, Xiangmei, Guo, Ju‐Tao, Wei, Lai, Lu, Fengmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028043/ https://www.ncbi.nlm.nih.gov/pubmed/31278760 http://dx.doi.org/10.1002/hep.30844 |
Ejemplares similares
-
Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients
por: Jung, Sang Kyung, et al.
Publicado: (2015) -
Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues
por: Wang, Yang, et al.
Publicado: (2022) -
Levels of HBV RNA in chronic HBV infected patients during first-line nucleos(t)ide analogues therapy
por: Jiang, Bei, et al.
Publicado: (2022) -
Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
por: Kim, Soon Sun, et al.
Publicado: (2011) -
Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis B
por: Lee, I-Cheng, et al.
Publicado: (2015)